The challenge of new inhalers

J. Kocks (Groningen, Netherlands)

Source: International Congress 2018 – Primary Care Programme 2018: Part II
Session: Primary Care Programme 2018: Part II
Session type: Session
Number: 147
Disease area: Airway diseases

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Kocks (Groningen, Netherlands). The challenge of new inhalers. International Congress 2018 – Primary Care Programme 2018: Part II

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Not all inhalers are the same: factors to consider when prescribing a new device inhaler
Source: Annual Congress 2010 - The essentials of aerosol therapy: what the practicing physician should know
Year: 2010


Ten questions about metered dose inhalers: the quality of patient‘s knowledge about aerosol therapy
Source: Eur Respir J 2005; 26: Suppl. 49, 514s
Year: 2005

Technique training doesn‘t improve patients ability to use pressurised metered dose inhalers (pMDIs)
Source: Annual Congress 2009 - Quality of treatment in primary respiratory care
Year: 2009


The effect of Clip-tone® and its smartphone application on optimization of metered-dose inhaler inhalation technique
Source: Virtual Congress 2020 – How to overcome deficiencies in skills in bedside training by virtual tools and simulation- where do we go?
Year: 2020




Long-term preference and ease of use of a novel dry powder inhaler with budesonide in comparison to a conventional inhaler in asthmatic children
Source: Eur Respir J 2001; 18: Suppl. 33, 121s
Year: 2001

Technique: the usual problem of metered dose inhalers
Source: Eur Respir J 2002; 20: Suppl. 38, 503s
Year: 2002

Efficacy and safety of salbutamol delivered via a novel multidose dry powder inhaler in comparison with two conventional dry powder inhalers and a pMDI in asthmatic subjects
Source: Eur Respir J 2001; 18: Suppl. 33, 50s
Year: 2001

The use of pressurized metered-dose inhalers mith spacer in the treatment of asthmatic crises: impacts on treatment costs
Source: Eur Respir J 2006; 28: Suppl. 50, 710s
Year: 2006

How does the Novolizer fit into the choice of inhaler?
Source: Annual Congress 2005 - Asthma management - important issues
Year: 2005

Do asthma patients achieve effective dosing from dry powder inhalers (DPIs)?
Source: Eur Respir J 2005; 26: Suppl. 49, 338s
Year: 2005

Salbutamol delivered via a new multi-dose dry powder inhaler is as safe and efficacious as a pressurised metered dose inhaler in children aged 6-12 years
Source: Eur Respir J 2002; 20: Suppl. 38, 501s
Year: 2002

How to select an inhaler?
Source: Virtual Congress 2020 – Inhalers for COPD and asthma: reviews
Year: 2020


Device handling study of a novel breath-actuated inhaler Synchrobreathe vs pMDI
Source: International Congress 2019 – COPD treatment: clinical trials, cohorts and inhaler device studies
Year: 2019

Bronchodilator response to salbutamol administered through metered-dose inhaler plus spacer or dry-powder inhaler in asthmatic patients
Source: Eur Respir J 2001; 18: Suppl. 33, 101s
Year: 2001

A novel approach of using pharmaceutical pictogram for improving asthma inhaler techniques
Source: International Congress 2018 – Pulmonary drug delivery: inhaler use, devices and technologies
Year: 2018


Comparison between traditional and nontraditional add-on devices used with pressurised metered-dose inhalers
Source: ERJ Open Res, 6 (4) 00073-2020; 10.1183/23120541.00073-2020
Year: 2020



The genuair® inhaler: a novel multidose dry powder inhaler for the delivery of various types of inhalation powder
Source: Annual Congress 2009 - New aspects of inhalation therapy
Year: 2009

Comparative in vitro performance of the new drug aclidinium in a novel multidose dry powder inhaler
Source: Annual Congress 2013 –New clinical trials of asthma and COPD drugs
Year: 2013

Impact of inhalation delay on medication delivery from a salbutamol HFA pressurized metered dose inhaler used with and without a new prototype portable valved holding chamber
Source: International Congress 2019 – COPD treatment: clinical trials, cohorts and inhaler device studies
Year: 2019